Introduction:
Gullain-Barré Syndrome (GBS) is an acute, frequently severe and fulminant demyelinating polyradiculoneuropathy that is autoimmune in nature. It is characterized by a rapidly ascending muscle weakness or paralysis accompanied by absent or depressed deep tendon reflexes and in some cases, by respiratory distress. Abnormal immune response against target epitopes in Schwann cell surface or myelin (demyelinating form-85%) or epitopes in axonal membrane (acute axonal form-15%) through both humoral and cell mediated mechanisms is the proposed aetiopathogenesis to explain GBS 1, 2, 3 .
Approximately 70% of cases of GBS occur 1-3 weeks after an acute infectious process, usually respiratory or gastrointestinal 4, 5 . Culture and seroepidemiologic techniques show that 30% cases are preceded by infection or reinfection by Campylobactor jejeuni 4 . Other factors that play role in triggering immune response for GBS are herpes simplex virus, CMV or Epstein-Barr virus, Mycoplasma pneumonia and some vaccines like swine flu vaccine, influenza vaccine & nerve tissue rabies vaccine. GBS can also occur more frequently than can be attributed to chance alone in patients with lymphoma (including Hodgkin's disease), in HIV-seropositive individual and in SLE patients 4 . Linkage of GBS with several other malignancies has been reported as possible paraneoplastic complications such as breast carcinoma, small cell carcinoma of the lungs , renal carcinoma and rarely in esophageal carcinoma 2, 6, 7, 8 . The effects of lymphoma on the peripheral nervous system have been reviewed in some articles. Many reports have been issued on GBS in association with Hodgkin's disease, but its association with Non-Hodgkin's Lymphoma (NHL) is relatively rare. A few cases of NHL reported developed acute motor neuropathy after or during receiving CHOP chemotherapy for the malignancy attributable to either chemotherapy induced polyneuropathy or demyelinating polyradiculoneuropathy (GBS) 3, 9 . We presents a case of acute motor neuropathy, likely GBS, with concomitant incidental finding of generalized lymphadenopathy which was later proven to be a case of NHL. It stresses the possibility of the occurrence of GBS in a patient of NHL and suggests that the full spectra of these disease entities are yet to be fully defined.
Case Report:
A 45 years old male smoker, day laborer, normotensive non-diabetic patient hailing from Jurain, Dhaka, was admitted in the neurology department of SSMC Mitford hospital on 1 st September 2011 with the complaints of low grade intermittent fever for two months, progressive weight loss for the same duration and sudden weakness of all four limbs for last seven days. Fever came at evening, was not associated with chill and rigor or any other organ specific symptoms & subsided spontaneously without sweating. He had no history of contact with known patient of TB. He noticed progressive loss of body weight in the last 2 months which was associated with loss of appetite but not with polyuria, polydipsia, heat intolerance or palpitation. One week ago he developed sudden weakness of left lower limb with diffuse dull aching pain. Weakness progressed to affect all four limbs in a period of 3-5 days and affected both proximal & distal muscles simultaneously. There was no bowel and bladder involvement or any definite sensory complain. There was no recent history of upper respiratory tract infection, diarrhoea or vaccination. There was no history of exposure to any chemical, toxin or drug.
On examination, the patient was cachectic & mildly anaemic & had generalized lymphadenopathy involving cervical and inguinal groups. Lymph nodes were in variable sizes and shapes, non-tender, firm in consistency, not fixed to underlying structure or skin. Liver was enlarged, non-tender, 7.5 cm from right subcostal margin in right mid-clavicular line, firm in consistency with a sharp margin with absent hepatic bruit. Spleen was also enlarged, 3.5 cm from left costal margin along its long axis, firm in consistency. Higher psychic function with speech and cranial nerves including fundus were normal, motor examination revealed flaccid quadriparesis (muscle power 0/5 both proximally and distally both side) with absence of all deep tendon reflexes. Planter response was absent on both sides. Sensory system was intact. Clinically the patient was diagnosed as a case of GBS.
Complete blood picture of the patient revealed Hb% -09 gm/dl, ESR 08 mm in 1 st hour and normal cell counts with a normal peripheral blood film. On biochemical screening RBS, SGPT, serum creatinine and serum electrolytes were normal. CXR P/A view & urine for R/ M/E were also normal. USG of whole abdomen revealed hepatosplenomegaly with normal echo texture. MT (Mantoux test) was negative. HIV-1 and HIV-2 screening test was negative. CSF study was performed on the 10th day of onset of weakness which demonstrated albumiono-cytological dissociation (protein 105 mg/dL and cell counts 10 cells/cmm, all lymphocytes) while other parameters were within normal limits. Nerve conduction study (crossed limbs) showed evidence of mixed peripheral neuropathy, both axonal and demyelinating, with evidence of radicular involvement (Fig 1-4. ) The clinical diagnosis of GBS was made according to international criteria. Later, a biopsy of right anterior chain of cervical lymph node was done and histopathological study was compatible with NonHodgkin's Lymphoma, high grade follicular type, with areas showing hemorrhage, fibrosis and crushing effects (Fig 5-6) . A staging Bone Marrow (BM) study was performed which revealed evidence of 
Discussion:
NHL is a neoplastic transformation of cells that reside predominantly within lymphoid tissues which may be of B or T cell origin. There is a slight male to female predominance and incidence steadily rises with age, especially after 40 years. Unlike Hodgkin's disease, NHL is much less predictable and has a greater predilection to involve extra nodal sites. It has been estimated that the nervous system is involved in about 10-25% of cases of NHL. 10 Primary Central Nervous system (CNS) involvement results in headache, seizures, lethargy, focal neurological symptom or paralysis. Uncommon CNS manifestation may include lymphomatous meningitis and spinal cord compression. On the other hand, peripheral nervous system involvement occurs in 5% patients with lymphoma and has a wide differential diagnosis, with Herpes Zoster being the commonest cause 9 . Five distinct types of polyneuropathy occur as an occasional remote accompaniment of lymphoma-GBS, chronic relapsing inflammatory demyelinating polyradiculoneuropathy (CIDP), paraneoplastic sensory neuropathy, sub acute motor neuropathy and diffuse infiltration of nerves by NHL 11 . However, the differential diagnosis of peripheral neuropathies in NHL depends on the clinical settings and mainly includes drug (chemotherapy) toxicity and nerve infiltration by lymphoma -both of which have been well described 3, 12 . Besides these, plexopathy, mononeuropathy, vasculitis and paraproteinemic deposition have all been postulated as the underlying etiology of acute neuropathies in NHL.
The Guillain-Barré Syndrome and chronic relapsing inflammatory demyelinating polyradiculoneuropathy (CIDP) probably reflect disordered immune regulation 11 . It seems likely that malignant tumors act as sources of the antigenic factors that are responsible for initiating an immune response in the nervous system, later manifesting as GBS 3 . Another theory is that selective depression of cell mediated immunity of any etiology might allow the development of a humoral and or cellular immune reaction directed against peripheral nerve antigens. There might also be other epigenetic factors that contribute to the development of GBS in any particular immune-compromised patient 13 .
Chemotherapy, especially with vinca alkaloids (vincristine, vinblastine etc) is probably the most common cause of peripheral neuropathy in patients with lymphoma. In fact, only 01 patient with NHL has been reported to develop GBS before the diagnosis and initiation of chemotherapy; all the rest developed GBS after initiation of CHOP or other chemotherapies 13 . Chemotherapy induced peripheral neuropathy (CIPN) manifest as painful dyesthesias and distal symmetrical sensorimotor neuropathy, predominantly involving large diameter fibers during the early stages. Nerve biopsy is a distinguishing point between GBS and CIPN (neurofilamentous accumulations within the axons are characteristic of CIPN, whereas GBS is characterized by intense lymphocytic infiltrations in the nerve roots and peripheral nerves (demyelinating type) or macrophages invading the periaxonal spaces of myelinated fibers (axonal type) 13 . However, GBS may occur even in a patient who received chemotherapy for NHL. The immunosuppressive status induced in these cases by the treatment could have confounded the real action of the malignancy in the development of GBS by enhancing the immunological-mediated myelin damage catalyzed normally by the tumor epitope 13 .
Diffuse and direct infiltration of peripheral nerves by NHL can produce a progressive, painful and asymmetrical polyneuropathy. This is termed as neurolymphomatosis and is a rare event, often occurring in the presence of widespread systemic disease 9, 11 .
Paraneoplastic neuropathy is a heterogeneous group of conditions that often presents as a sub acute sensory neuropathy. Less frequently seen paraneoplastic presentations include motor sensory neuropathies, autonomic neuropathies and lower motor neuron syndromes 13 . Paraneoplastic syndrome is extremely rare in cancer patients with an estimated incidence of about 7% 2 . The commonly proposed criteria to define a paraneoplastic disease are based on the increased incidence of a specific cancer in a population affected by a particular neurological disorder, the short latency between the onset of the neuropathy, the presence of specific onco-neural antibodies directed against antigens expressed by the tumor and the nervous system cells and the absence of other causes explaining the pathogenesis of the neuropathy 2 . However in contrast to other neurological syndromes which usually express onco-neural antibodies, tumor associated GBS has no specific serological profile to be used in clinical practice. So, defining GBS as a paraneoplastic syndrome is not always conclusive.
In the presented case, our first clinical impression was acute motor neuropathy (GBS?) with lymphoma. The differentials included paraneoplastic motor neuropathy due to any malignancy. Toxic or metabolic causes of the neuropathy were excluded as far as possible. CSF and NCS study suggested that it was a case of polyradiculoneuropathy (both demyelinating and axonal). As lymph node biopsy revealed the histological proof of NHL, a diagnosis of GBS in association with NHL was made, which is a rare one. The cause of this GBS was obviously not due to chemotherapy or neurolymphomatosis. The nature of this relationship, whether, paraneoplastic or an immunologic association remains uncertain.
Conclusion:
In conclusion, we reported this case as an uncommon association between NHL and GBS, which was diagnosed concomitantly at the first presentation in a 45 years old male patient. Most reported GBS cases associated with NHL was diagnosed after receiving chemotherapy. The study stresses that a GBS neuropathy of undetermined origin may be associated with underlying malignancy and NHL, though rare, must be included in the differential diagnosis. The study might also provide further insight into the underlying etiology of this syndrome and lead to the development of targeted immunomodulatory therapies that are more specific, less toxic and more beneficial than those currently available.
